Author:
González-Restrepo Daniel Santiago,de la Cruz Catalina,López-Medina Eduardo
Reference18 articles.
1. Whittaker E, Bamford A, Kenny J et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA. 2020; 324 (3): 259-269.
2. Nakra N, Blumberg D, Herrera-Guerra A, Lakshminrusimha S. Multi-system inflammatory syndrome in children (MIS-C) following SARS-CoV-2 infection: review of clinical presentation, hypothetical pathogenesis, and proposed management. Children. 2020; 7 (7): 69.
3. Jiang L, Tang K, Irfan O, Li X, Zhang E, Bhutta Z. Epidemiology, clinical features, and outcomes of multisystem inflammatory syndrome in children (MIS-C) and adolescents-a live systematic review and meta-analysis. Curr Pediatr Rep. 2022; 10 (2): 19-30.
4. Shi H, Weng F, Li C et al. Overweight, obesity and coronary artery lesions among Kawasaki disease patients. Nutr Metab Cardiovasc Dis. 2021; 31 (5): 1604-1612.
5. De La Cruz C, Herbst K, Davalos D et al. Multisystem inflammatory syndrome in children associated with COVID-19: a comparison study between cohorts from different geographic locations. Infecto. 2022; Suppl. 4.